Aqua Bio Technology ASA – further distribution of the skin care series Cuvget in EMEA

Reference is made to the announcement of 12 January, 2017 regarding Aqua Bio
Technology's (ABT) distribution agreement with Scandiderma AS (Scandiderma) for
the distribution of the skin care series Cuvget (the Distribution Agreement).

As per the Distribution Agreement, ABT has been holding exclusive distribution
rights for Cuvget in EMEA (Europe, the Middle East and Africa).

The market response to the Cuvget products in their present form, as well as the
sales of the skin care series, have failed to mirror ABT's expectations.
Therefore, ABT has decided not to meet its commitments related to the minimum
order set out in the Distribution Agreement and its appendices.

ABT and Scandiderma have been engaged in negotiations over a new, exclusive
distribution agreement and a reformulation of the skin care series. However, the
parties have not succeeded in agreeing on the terms for a further exclusive
cooperation. Going forward, ABT will therefore sell Cuvget on a non-exclusive
basis in the EMEA, something which is expected to be more challenging under
ABT's current business model.

The main ingredient in Cuvget is Arctic Chaga, a fungus found on birch trees in
the Arctic. The substance has been known in Russian and Sami nature medicine for
centuries. ABT holds a patent for the use of Chaga fungus in a certain
concentration for use in cosmetic products. ABT strongly believes in the
potential of Chaga fungus as an ingredient in cosmetic products. The termination
of the exclusivity related to the distribution of Cuvget will not influence
ABT's patent rights.


For further informatioin, please contact Espen Kvale, acting CEO, telephone
+47 9162 8092.


Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on the Axess market of the
Oslo Stock Exchange.


This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.